EssexBio

Essex-Bio Group

简繁 EN

SCIENTIFIC ACTIVITIES

bFGF alleviated dry eye disease by modulating inflammatory response and promoting healing process both in vitro and in vivo.

2021.05.06

Date

Title

2021-05-06

bFGF alleviated dry eye disease by modulating inflammatory response and promoting healing process both in vitro and in vivo. ARVO 2021 Annual Meeting

2020-12-24

Tackling solid tumour therapy with small-format drug conjugates. Antibody Therapeutics, 2020, Vol. 3, No. 4

2019-07-31

Safety and Efficacy of First-in-Class mtROS scavenger SkQ1 for the Treatment of Dry Eye Disease: A Phase 3 Clinical Trial . Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6750. doi:

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT